Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-methyl-4-aminoazobenzene
1. 621-90-9
2. N-methyl-4-aminoazobenzene
3. P-monomethylaminoazobenzene
4. 4-monomethylaminoazobenzene
5. N-methyl-p-aminoazobenzene
6. N-methyl-4-(phenyldiazenyl)aniline
7. N-methyl-4-phenyldiazenylaniline
8. N-methyl-p-(phenylazo)aniline
9. P-n-methylaminoazobenzene
10. Benzenamine, N-methyl-4-(phenylazo)-
11. Aniline, N-methyl-p-(phenylazo)-
12. 44n974bfdi
13. Mab
14. Ccris 382
15. N-methyl-4-(phenylazo)benzenamine
16. 4-methylaminoazobenzene
17. Unii-44n974bfdi
18. P-(phenylazo)-n-methylaniline
19. Schembl5982612
20. (e)-4-(methylamino)azobenzene
21. Dtxsid201023342
22. Mfcd00059198
23. Monomethylaminoazobenzene, 4-
24. Zinc21299786
25. N-methyl-4-[phenyldiazenyl]aniline #
26. Zinc100020723
27. Zinc242463772
28. (e)-n-methyl-4-(phenyldiazenyl)aniline
29. N-methyl-4-(2-phenyldiazen-1-yl)aniline
30. N-methyl-n-[4-(phenyldiazenyl)phenyl]amine
31. Ft-0704252
32. M0143
33. D91285
34. Ae-562/43459099
35. Q27889325
36. 42472-83-3
| Molecular Weight | 211.26 g/mol |
|---|---|
| Molecular Formula | C13H13N3 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 211.110947427 g/mol |
| Monoisotopic Mass | 211.110947427 g/mol |
| Topological Polar Surface Area | 36.8 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 213 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A P-N-Methylaminoazobenzene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of P-N-Methylaminoazobenzene, including repackagers and relabelers. The FDA regulates P-N-Methylaminoazobenzene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. P-N-Methylaminoazobenzene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A P-N-Methylaminoazobenzene supplier is an individual or a company that provides P-N-Methylaminoazobenzene active pharmaceutical ingredient (API) or P-N-Methylaminoazobenzene finished formulations upon request. The P-N-Methylaminoazobenzene suppliers may include P-N-Methylaminoazobenzene API manufacturers, exporters, distributors and traders.
click here to find a list of P-N-Methylaminoazobenzene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The P-N-Methylaminoazobenzene Drug Master File in Japan (P-N-Methylaminoazobenzene JDMF) empowers P-N-Methylaminoazobenzene API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the P-N-Methylaminoazobenzene JDMF during the approval evaluation for pharmaceutical products. At the time of P-N-Methylaminoazobenzene JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of P-N-Methylaminoazobenzene suppliers with JDMF on PharmaCompass.
P-N-Methylaminoazobenzene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of P-N-Methylaminoazobenzene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right P-N-Methylaminoazobenzene GMP manufacturer or P-N-Methylaminoazobenzene GMP API supplier for your needs.
A P-N-Methylaminoazobenzene CoA (Certificate of Analysis) is a formal document that attests to P-N-Methylaminoazobenzene's compliance with P-N-Methylaminoazobenzene specifications and serves as a tool for batch-level quality control.
P-N-Methylaminoazobenzene CoA mostly includes findings from lab analyses of a specific batch. For each P-N-Methylaminoazobenzene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
P-N-Methylaminoazobenzene may be tested according to a variety of international standards, such as European Pharmacopoeia (P-N-Methylaminoazobenzene EP), P-N-Methylaminoazobenzene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (P-N-Methylaminoazobenzene USP).
LOOKING FOR A SUPPLIER?
